Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCABIL for Leber Hereditary Optic Neuropathy (Exploratory Study)
jRCTs051250052Active, not recruiting
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tauroursodeoxycholic acid in Leber hereditary optic neuropathy (LHON), sponsored by Ministry of Health, Labour and Welfare. Started Sep 2025; status: active, not recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on jRCTs051250052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250052.